Cargando…
Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic “Neo-Islets”, 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes
Novel biotherapies for Type 1 Diabetes that provide a significantly expanded donor pool and that deliver all islet hormones without requiring anti-rejection drugs are urgently needed. Scoring systems have improved islet allotransplantation outcomes, but their use may potentially result in the waste...
Autores principales: | Gooch, Anna M., Chowdhury, Sabiha S., Zhang, Ping M., Hu, Zhuma M., Westenfelder, Christof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449143/ https://www.ncbi.nlm.nih.gov/pubmed/37616230 http://dx.doi.org/10.1371/journal.pone.0290460 |
Ejemplares similares
-
Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of “Neo‐Islets,” Three‐Dimensional Aggregates of Allogeneic Islet and “Mesenchymal Stem Cells”
por: Westenfelder, Christof, et al.
Publicado: (2017) -
Intraperitoneal administration of human “Neo-Islets”, 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials
por: Westenfelder, Christof, et al.
Publicado: (2021) -
Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using “Neo-Islets,” aggregates of adipose stem and pancreatic islet cells (INAD 012-776)
por: Gooch, Anna, et al.
Publicado: (2019) -
The Current Status of Allogenic Islet Cell Transplantation
por: Czarnecka, Zofia, et al.
Publicado: (2023) -
Islet organoid as a promising model for diabetes
por: Zhang, Xiaofei, et al.
Publicado: (2021)